Stockreport

Roche's CT-388 Adds Optionality In The GLP Market, But Wait For Dips [Seeking Alpha]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF Roche's Genentech plans to start its Phase 3 this quarter, but primary completion will happen by 2028. Thus, this new GLP bet is inherently still a long-term thesis, [Read more]